Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2

被引:23
作者
Stanford, SJ
Pepper, JR
Mitchell, JA
机构
[1] Royay Brompton & Harefield NHS Trust, Imperial Coll Sch Med, Crit Care Unit, London SW3 6NP, England
[2] Royay Brompton & Harefield NHS Trust, Imperial Coll Sch Med, Dept Cardiothorac Surg, London SW3 6NP, England
关键词
cyclo-oxygenase-2; G-CSF; GM-CSF; smooth muscle cells; prostacyclin;
D O I
10.1038/sj.bjp.0703151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to their traditional contractile function, vascular smooth muscle cells can be stimulated under inflammatory conditions to release a range of potent biological mediators. Indeed, we and others have shown that human vascular smooth muscle release the colony stimulating factors (CSF) granulocyte macrophage-CSF (GM-CSF) and granulocyte-CSF (G-CSF) as well as large amounts of prostaglandins following the induction of cyclo-oxygenase-2 (COX-2), when stimulated with cytokines. Here we demonstrate, for the first time, that co-induced COX-2 activity simultaneously suppresses GM-CSF release and potentiates G-CSF release by human vascular cells. Moreover, the differential regulation of GM-CSF and G-CSF release by COX-2 was mimicked by the prostacyclin (PGI(2)) mimetic, cicaprost. These observations suggest that PGI(2), released following the induction of COX-2, differentially regulates the release of GM-CSF (suppresses) and G-CSF (potentiates) from human vascular cells.
引用
收藏
页码:835 / 838
页数:4
相关论文
共 15 条
[1]  
Agro A, 1996, J RHEUMATOL, V23, P862
[2]   Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle - Role of endogenous prostanoids [J].
Bishop-Bailey, D ;
Pepper, JR ;
Larkin, SW ;
Mitchell, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1655-1661
[3]  
COLOTTA F, 1992, BLOOD, V80, P2012
[4]   LONG-TERM CULTURES OF HUMAN MONOCYTES INVITRO - IMPACT OF GM-CSF ON SURVIVAL AND DIFFERENTIATION [J].
EISCHEN, A ;
VINCENT, F ;
BERGERAT, JP ;
LOUIS, B ;
FARADJI, A ;
BOHBOT, A ;
OBERLING, F .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 143 (02) :209-221
[5]   EXAMINATION OF SURVIVAL, PROLIFERATION AND CELL-SURFACE ANTIGEN EXPRESSION OF HUMAN MONOCYTES EXPOSED TO MACROPHAGE COLONY-STIMULATING FACTOR (M-CSF) [J].
ERICKSONMILLER, CL ;
BRENNAN, JK ;
ABBOUD, CN .
INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (05) :346-356
[6]  
HAMILTON JA, 1992, BLOOD, V79, P1413
[7]   DIFFERENTIAL EXPRESSION OF M-CSF, G-CSF, AND GM-CSF BY HUMAN MONOCYTES [J].
LEE, MT ;
KAUSHANSKY, K ;
RALPH, P ;
LADNER, MB .
JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (03) :275-282
[8]   RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES INVITRO MATURE HUMAN NEUTROPHIL AND EOSINOPHIL FUNCTION, SURFACE-RECEPTOR EXPRESSION, AND SURVIVAL [J].
LOPEZ, AF ;
WILLIAMSON, DJ ;
GAMBLE, JR ;
BEGLEY, CG ;
HARLAN, JM ;
KLEBANOFF, SJ ;
WALTERSDORPH, A ;
WONG, G ;
CLARK, SC ;
VADAS, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1220-1228
[9]   Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells [J].
Luttmann, W ;
Herzog, V ;
Virchow, JC ;
Matthys, H ;
Thierauch, KH ;
Kroegel, C .
PULMONARY PHARMACOLOGY, 1996, 9 (01) :43-48
[10]  
METCALF D, 1986, BLOOD, V67, P257